Tricuspid Regurgitation Latest Advances

Asian Pacific Society of Cardiology Consensus Statements on the Use of Transcatheter Edge-to-Edge Repair in the Treatment of Tricuspid and Mitral Regurgitation.

Journal: JACC. Asia

Published: April 15, 2026

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

Journal: JAMA

Published: April 13, 2026

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Journal: Annals of medicine

Published: April 10, 2026

Response to SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: April 08, 2026

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Journal: Journal of cardiovascular pharmacology

Published: April 08, 2026

Decoding the TR Enigma: Cardiac Index Phenotypes, Congestion, and Prognosis.

Journal: Circulation. Cardiovascular imaging

Published: April 06, 2026

Non-Healing Venous Ulcer Associated With the Triple Threat of Deep Vein Reflux, Tricuspid Valve Regurgitation, and Pulmonary Hypertension.

Journal: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

Published: April 03, 2026

SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: March 30, 2026

Liver Disease in Tricuspid Regurgitation: From Congestion to Cirrhosis.

Journal: European journal of heart failure

Published: March 27, 2026

Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.

Journal: Circulation. Cardiovascular interventions

Published: March 26, 2026

Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.

Journal: Circulation. Cardiovascular interventions

Published: March 26, 2026

Operator and Institutional Recommendations and Requirements for Tricuspid Interventions: 2026 ACC/AHA/ASE/HRS/STS Expert Consensus Systems of Care Document: A Joint Report of the American College of Cardiology, the American Heart Association, the American Society of Echocardiography, the Heart Rhythm Society, and the Society of Thoracic Surgeons.

Journal: Journal of the American College of Cardiology

Published: March 25, 2026

Tricuspid Regurgitation Latest Advances

Find the Latest Research About Tricuspid Regurgitation

Asian Pacific Society of Cardiology Consensus Statements on the Use of Transcatheter Edge-to-Edge Repair in the Treatment of Tricuspid and Mitral Regurgitation.

Asian Pacific Society of Cardiology Consensus Statements on the Use of Transcatheter Edge-to-Edge Repair in the Treatment of Tricuspid and Mitral Regurgitation.

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Prognostic value of peak tricuspid regurgitation velocity in hospitalized patients with heart failure with preserved ejection fraction: an multi-institutional study.

Response to SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

Response to SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.

Decoding the TR Enigma: Cardiac Index Phenotypes, Congestion, and Prognosis.

Decoding the TR Enigma: Cardiac Index Phenotypes, Congestion, and Prognosis.

Non-Healing Venous Ulcer Associated With the Triple Threat of Deep Vein Reflux, Tricuspid Valve Regurgitation, and Pulmonary Hypertension.

Non-Healing Venous Ulcer Associated With the Triple Threat of Deep Vein Reflux, Tricuspid Valve Regurgitation, and Pulmonary Hypertension.

SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future Directions.

Liver Disease in Tricuspid Regurgitation: From Congestion to Cirrhosis.

Liver Disease in Tricuspid Regurgitation: From Congestion to Cirrhosis.

Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.

Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.

Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.

Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.